2. INTRODUCTION
Most common parasitic disease of the CNS worldwide
Most common cause of acquired epileptic seizure In developing
countries
Causative agent: larval stage T. solium/pork tapeworm
Ingestion of food contaminated with the eggs of the parasite T.
solium
3. INTRODUCTION
Cysticerci: most commonly detected in the brain, CSF, skeletal muscle,
subcutaneous tissue, or eye.
Clinical presentation:
Depends on the number and location of cysticerci
Extent of associated inflammatory responses or scarring
5. CLINICAL FEATURES
Neurologic manifestations are the most common
Seizures: generalized/focal
Hydrocephalus may result from CSF flow obstruction by cysticerci
and accompanying inflammation or by CSF outflow obstruction from
arachnoiditis.
6. CLINICAL FEATURES
Symptoms of increased intracranial pressure
Headache
Nausea
Vomiting
Changes in vision
Dizziness
Ataxia
7. CLINICAL FEATURES
Patients with hydrocephalus may develop papilledema or
display altered mental status.
When cysticerci develop at the base of the brain or in the sub-
arachnoid space, they may cause chronic meningitis or
arachnoiditis, communicating hydrocephalus, haemorrhages, or
strokes
8. DIAGNOSIS
MRI or CT scans - appear as cystic lesions/scolex can often be
visualized
Lesions may appear as contrast- enhancing lesions surrounded
by edema.
Parenchymal brain calcifications are the most common finding
and evidence that the parasite is no longer viable.
CSF- to rule out other causes
9. STAGES
Stage
Vesicular Cyst & scolex
Colloidal Ring enhancement and
edema
Granular Decreased enhancement
and edema
Involution Calcification
12. ANTIEPILEPTICS
Initiated when the patient presents with a seizure
Stopped once the follow-up CT scan shows resolution of the
lesion
Long-term antiepileptic therapy is recommended when
seizures occur after resolution of edema and resorption or
calcification of the degenerating cyst.
13. ANTHELMINTIC
Cysticidal drugs accelerate the destruction of the parasites,
resulting in a faster resolution of the infection
For lesions that are in the “granulo-nodular” stage (surrounded
by a contrast-enhancing ring)
Calcified lesions do not need to be treated with anticysticidal
therapy.
Albendazole
Praziquantel
14. ALBENDAZOLE
Mechanism of action: Binds to free β-tubulin in nematodes,
inhibiting the polymerization of tubulin and the microtubule-
dependent uptake of glucose. Irreversible damage occurs in
gastrointestinal (GI) cells of the nematodes, resulting in
starvation, death, and expulsion by the host.
Dose: 15 mg/kg per day in two doses for 8 – 28 days
Maximum 800 mg/day
15. ALBENDAZOLE
Poorly absorbed from the GI tract
Metabolized in the liver
Administration with a high-fat meal (~40 g) increases the
drug’s absorption
Albendazole sulfoxide (metabolite) crosses the blood–brain
barrier
16. ALBENDAZOLE
Prolonged courses- associated with liver function abnormalities
and bone marrow toxicity.
Drug should be administered in treatment cycles of 28 days
interrupted by 14-day intervals off therapy
17. PRAZIQUANTEL
Mechanism of action: increases the permeability of the
membranes of schistosome cells towards calcium ions.
Induces contraction of the parasites muscle, resulting in
paralysis
Dose: 50–100 mg/kg daily in three divided doses for 15–30
days
A combination of albendazole and praziquantel is more
effective in patients with more than two cystic lesions.
19. STEROIDS
Prednisone- 1-2 mg/kg/day
Dexamethasone – 0.1mg/kg/day IV starting one day before
anthelmintic
To reduce the host inflammatory response to degenerating
parasites
Glucocorticoids induce first-pass metabolism of praziquantel
and may decrease its antiparasitic effect, cimetidine should be
co-administered to inhibit praziquantel metabolism
Serum levels of phenytoin and Carbamazepine may also be
altered
20. FOR HYDROCEPHALUS
In the case of obstructive hydrocephalus, the preferred
approach is removal of the cysticercus via endoscopic surgery.
Alternative approach - diverting procedure-
ventriculoperitoneal shunting
Prolonged courses of antiparasitic drugs
Methotrexate should be used as a steroid-sparing agent in
patients requiring prolonged therapy
23. PREVENTION
Good personal hygiene
Treatment and prevention of human intestinal infections.
Adequate cooking of pork viscera
Exposure to temperatures as low as 56°C for 5 min will destroy
cysticerci
24. PREVENTION
Refrigeration/salting for long periods or freezing at –10°C for 9 days also
kills cysticerci
Inspection of beef and proper disposal of human feces
Mass chemotherapy - in efforts at disease eradication
Vaccines are under development.
Adult tapeworms in the intestine
Larval forms in the tissues (cysticercosis)
Cysticerci can be found anywhere in the body but are most commonly detected in the brain, cerebrospinal fluid (CSF), skeletal muscle, subcutaneous tissue, or eye.
A very early sign of cyst death is hypointensity of the vesicular fluid on T2-weighted images when compared with CSF.
MRI findings of toxoplasmosis consist of multiple lesions in the deep white matter, the thalamus, and basal ganglia and at the gray-white junction in the cerebral hemispheres. With contrast admin- istration, the majority of the lesions enhance in a ringed, nodular, or homogeneous pattern and are surrounded by edema. In the presence of the characteristic neuroimaging abnormalities of T. gondii infection, serum IgG antibody to T. gondii should be obtained and, when positive, the patient should be treated.
Cysticerci appearing as cystic lesions in the brain parenchyma with or without pericystic edema or in the subarachnoid space at the convexity of the cerebral hemispheres should be treated with anticysticidal therapy.
There is controversy about whether or not anthelmintic therapy should be given to all patients, and recommendations are based on the stage of the lesion
Available as – 400 and 200 mg tab
Prolonged therapy with full-dose albendazole (800 mg/d) should be approached cautiously in patients also receiving drugs with known effects on the cytochrome P450 system.
Avl as 600mg tabs
Only cysts in the vesicular stage, where the cyst contains living larva (scolex seen on CT or MRI), and cysts in the colloidal stage as the larva degnerates (edema surrounds the lesion), are treated with anticysticidal therapy
Historically, shunts have usually failed, but failure rates have been lowered by administration of antiparasitic drugs and glucocorticoids. Open craniotomy to remove cysticerci is now required only infrequently but is effective for fourth-ventricular cysticerci. For patients with subarachnoid cysts or giant cysticerci, anti-inflammatory medica- tions such as glucocorticoids are needed to reduce arachnoiditis and accompanying vasculitis.
For ocular and spinal medullary lesions, drug-induced inflammation may cause irrevers- ible damage. Ocular disease should be managed surgically. Recent data suggest that either medical or surgical therapy can be used for spinal disease.